Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Genetic Technologies Limited ( - SIC # 8071 - MEDICAL LABORATORIES
Ticker
Exchange
SIC #
Website
Latest Ticker
GENE
Nasdaq
8071
https://www.gtglabs.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Genetic Technologies Limited (
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
- Apr 22nd, 2024 7:00 pm
Genetic Technologies Announces $2 Million Registered Direct Offering
- Apr 18th, 2024 4:17 pm
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
- Apr 17th, 2024 12:00 pm
GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
- Apr 16th, 2024 12:00 pm
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
- Apr 12th, 2024 1:00 pm
GTG to pilot GeneType in Breast Screen centers across the U.S.
- Apr 11th, 2024 12:00 pm
EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”
- Apr 8th, 2024 12:00 pm
Genetic Technologies’ Digital Strategy Ignites Significant Traction in US Market
- Apr 2nd, 2024 12:05 pm
GTG Global Collaborations and Innovation Update
- Mar 26th, 2024 12:00 pm
GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
- Mar 25th, 2024 12:00 pm
One Genetic Technologies Insider Raised Stake By 20% In Previous Year
- Mar 8th, 2024 8:32 pm
GTG to launch U.S. Customer Digital Media Sales Campaign
- Feb 28th, 2024 1:00 pm
Launching our most comprehensive test and expanding into new global markets
- Jan 31st, 2024 1:00 pm
Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement
- Jan 5th, 2024 1:00 pm
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
- Dec 29th, 2023 2:00 pm
GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness
- Dec 14th, 2023 1:00 pm
Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change
- Dec 12th, 2023 1:00 pm
Here's Why Shareholders May Want To Be Cautious With Increasing Genetic Technologies Limited's (ASX:GTG) CEO Pay Packet
- Nov 15th, 2023 8:26 pm
Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial
- Oct 30th, 2023 12:00 pm
GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment
- Oct 18th, 2023 12:30 pm
Scroll